Target Organs
Equine Herpesvirus 1 Bridles T Lymphocytes To Reach Its Target Organs
26
Sex differences of inflammation in target organs, induced intraperitoneal injection of lipopolysaccharide, depend on its dose
15
Sub-chronic inhalation of lead oxide nanoparticles revealed their broad distribution and tissue-specific subcellular localization in target organs
19
Target organs for lymphocystis disease virus replication in gilthead seabream (Sparus aurata)
11
Acquisition of viral DNA sequences in target organs of chickens infected with avian myeloblastosis virus.
7
Thioredoxin 1 confines T cell alloresponse and pathogenicity in graft versus host disease
16
Gene expression studies of host response to Salmonid alphavirus subtype 3 experimental infections in Atlantic salmon
10
Different approaches for objective scoring of experimental post-operative adhesions in the rat model—a description
5
Cytokine mediators of chronic graft versus host disease
13
Therapeutic arthropods and other, largely terrestrial, folk-medicinally important invertebrates: a comparative survey and review
31
Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans
10
Subchronic oral toxicity of silver nanoparticles
11
Impacts of microcystin, a cyanobacterial toxin, on laboratory rodents in vivo
12
Preparation and preclinical evaluation of a 68Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me
11
Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome
8
Detection of Visna Maedi virus in mesenteric lymph nodes and in other lymphoid tissues of sheep three years after respiratory infection
5
Analysis of apyrase 5' upstream region validates improved Anopheles gambiae transformation technique
7
Knowledge gaps in host-parasite interaction preclude accurate assessment of meat-borne exposure to Toxoplasma gondii
24
Regulation of the synthesis of nerve growth factor
18
THE EFFECT OF USING PET CT FUSION ON TARGET VOLUME DELINEATION AND DOSE TO ORGANS AT RISK IN 3D RADIOTHERAPY PLANNING OF PATIENTS WITH NSSLC
6